Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2010
12/22/2010CN1914208B Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives
12/22/2010CN101925616A Photolatent amidine bases for redox curing of radically curable formulations
12/22/2010CN101925603A Modulators of cystic fibrosis transmembrane conductance regulator
12/22/2010CN101925595A Phthalazinone derivatives
12/22/2010CN101925586A Novel heterocyclic compounds
12/22/2010CN101921278A Tri-thiol porphyrin with 6-carbon atom main chain
12/22/2010CN101921277A Method for simultaneously preparing vasicine and vasicinone from peganum harmala
12/22/2010CN101423524B Diglutamate derivates and application thereof in preparation of pemetrexed
12/22/2010CN101418000B DPP-IV inhibitor derivates containing benzofuran sulfonyl ureas
12/22/2010CN101072779B 2,4 (4,6) pyrimidine derivatives
12/22/2010CN101048406B Novel substituted imidazole derivatives
12/21/2010US7855295 Tetrahydrocarboline compounds as anticancer agents
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/21/2010US7855288 For treatment of cytokine-associated conditions
12/21/2010US7855216 e.g. 3-(4-Bromo-2-fluoro-phenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridine-2-carboxylic acid ethyl ester; MEK kinase (Mitogen-Activated protein kinase kinase) inhibitor; anticarcinogenic, antiinflammatory agent; rheumatoid arthritis
12/21/2010US7855214 Autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease; inhibitors of the Tec family of non-receptor tyrosine kinases; compounds are quinazolino[3,2-a]quinazolin-12-ones
12/21/2010US7855206 antidiabetic agents such as (1S,2R,5S)-5-(2-Methyl-6,8-dihydro-7H-pyrazolo[1,5-a]pyrrolo[3,4-e]pyrimidin-7-yl)-2-(2,4,5-trifluorophenyl)cyclohexanamine bis-hydrochloride salt, used for treating non-insulin dependent diabetes
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010US7854797 prepared by reacting a porphyrazine compound containing 1 or 2 nitrogen containing heteroaromatic rings and rest benzene rings in its nucleus structure with an aminoalkyl-1,3,5-triaminotriazine compound in presence of ammonia; ozone colorfastness; ink jet recording
12/21/2010CA2598774C Method of reducing alpha, beta unsaturated ketones in opioid compositions
12/21/2010CA2580833C Method of preparing poly(adp-ribose) polymerases inhibitors
12/21/2010CA2441386C Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
12/21/2010CA2408596C New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/21/2010CA2406255C Hydroxylamine esters as polymerization initiators
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/21/2010CA2369895C High affinity inhibitors for target validation and uses thereof
12/16/2010WO2010143803A2 New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same
12/16/2010WO2010142652A1 Imidazobenzazepine compounds for the treatment of central nervous system (cns) diseases
12/16/2010WO2010142216A1 PYRAZOLO-[1,5-a]-PYRIMIDONES DERIVATES AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
12/16/2010WO2007069847A9 Novel imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same
12/16/2010US20100317966 Hybrid-multimodal magneto-optical contrast markers
12/16/2010US20100317870 Antimicrobial polymers
12/16/2010US20100317856 Process for the preparation of r-sitagliptin and its pharmaceutically acceptable salts thereof
12/16/2010US20100317832 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation
12/16/2010US20100317704 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter
12/16/2010US20100317690 Treatment of protein folding disorders
12/16/2010US20100317665 Anti-Inflammatory And Protein Kinase Inhibitor Compositions And Related Methods For Downregulation Of Detrimental Cellular Responses And Inhibition Of Cell Death
12/16/2010US20100317661 Small molecule inhibitors of mdm2 and the uses thereof
12/16/2010US20100317645 Substituted diazepine sulfonamides as bombesin receptor subtype-1 modulators
12/16/2010US20100317624 Heterocyclic urea derivatives and methods of use thereof
12/16/2010US20100316656 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
12/16/2010US20100316607 Hepatitis c virus inhibitors
12/15/2010EP2262030A2 Organic light emitting device
12/15/2010EP2261226A1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2260039A1 Chalcone linked pyrrolo[2,1-c[[1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
12/15/2010EP2260036A2 Polycyclic organic compounds, retardation layer and compensation panel on their base
12/15/2010EP2260035A2 Polycyclic organic compounds, polarizing elements and method of production thereof
12/15/2010EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/15/2010EP1692508B1 Membrane-based lateral flow assay devices that utilize phosphorescent detection
12/15/2010EP1634883B1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d] pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
12/15/2010EP1594873B1 Pyrrolidinohydrochinazolines
12/15/2010CN1993362B 稠合的杂环化合物 Fused heterocyclic compound
12/15/2010CN1988848B Carboranylporphyrins and uses thereof
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN101918410A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
12/15/2010CN101918409A Biaryl substituted diazabicycloalkane derivatives
12/15/2010CN101918408A Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
12/15/2010CN101918407A Beta-lactamase inhibitors
12/15/2010CN101918406A Compounds for the treatment of hepatitis c
12/15/2010CN101918079A Protein kinase inhibitors and use thereof
12/15/2010CN101917999A Modulation of protein trafficking
12/15/2010CN101917995A POLO-like kinase inhibitors
12/15/2010CN101914101A Preparation method of pyrrolizidine-9-acetic acid hydrochloride
12/15/2010CN101914100A Benzenesulfonyl lupetazin derivative and preparation method thereof
12/15/2010CN101914099A Covalently linked oligonucleotide minor groove binder conjugates
12/15/2010CN101912400A 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido[2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer
12/15/2010CN101180299B Acetylenyl-pyrazolo-pvrimidine derivatives as MGLUR2 antagonists
12/15/2010CN101102766B Novel derivatives of porphyrin, particularly chlorins and/orbacteriochlorins, and uses thereof in photodynamic therapy
12/15/2010CN101084220B Halogen substituted benzodiazepine derivatives
12/14/2010US7851644 Heterocyclic metallocenes and polymerization catalysts
12/14/2010US7851468 Substituted pyrazolo[3,4-d]pyrimidines
12/14/2010US7851464 Spirolactam aryl CGRP receptor antagonists
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2355939C Antihistaminic spiro compounds
12/09/2010WO2010141817A1 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
12/09/2010WO2010141809A1 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/09/2010WO2010141330A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
12/09/2010WO2010141273A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
12/09/2010WO2010140168A1 Improved process for preparing temozolomide
12/09/2010WO2010139483A1 Glycine b antagonists
12/09/2010WO2010139288A1 5,7-disubstituted 3-isopropylpyrazolo[4,3-d]pyrimidines for use as medicaments and pharmaceutical compositions
12/09/2010WO2010139256A1 Adduct formed by phosphodiesterase inhibitor and isoflavone and use thereof
12/09/2010WO2010095849A3 Acid addition salt of udenafil, preparation method thereof and phamaceutical composition comprising the same
12/09/2010WO2010093191A3 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
12/09/2010WO2010093128A3 Amphiphilic porphyrin derivatives and method for preparing the same
12/09/2010WO2010091386A3 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
12/09/2010US20100311762 Reduction of toxicity of multi-targeting antifolates
12/09/2010US20100311757 Salarins And Tulearins, Compositions And Uses Thereof
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311729 Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors
12/09/2010US20100311713 Novel Azetidine Compounds Useful in the Treatment of Functional Gastrointestinal Disorders, Ibs and Functional Dyspepsia
12/09/2010US20100311593 Haloalkylmethyleneoxyphenyl-substituted ketoenols
12/09/2010CA2764296A1 Derivatives of 6,7-dihydro-5h-imidazo[1,2-.alpha.]imidazole-3-carboxylic acid amides
12/08/2010EP2258703A1 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2010EP2258690A1 Tricyclic amines as intermediates in the synthesis of fungicidal carboxamide derivatives
12/08/2010EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 573